Van ECK Associates Corp Makes New $38,000 Investment in Avidity Biosciences, Inc. (NASDAQ:RNA)
Van ECK Associates Corp purchased a new stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 1,315 shares of the biotechnology company’s stock, valued at approximately $38,000. A number of other institutional investors and hedge funds also recently added to or reduced their […]
Van ECK Associates Corp purchased a new stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 1,315 shares of the biotechnology company’s stock, valued at approximately $38,000. A number of other institutional investors and hedge funds also recently added to or reduced their […]
